Canada Pension Plan Investment Board’s RAPT Therapeutics RAPT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,800	Closed	-$298K	–	1951
2025 Q4	$298K	Buy	+8,800	New	+$273K	﹤0.01%	1519
2021 Q2	–	Sell	-8,750	Closed	-$1.55M	–	1326
2021 Q1	$1.55M	Buy	+8,750	New	+$1.44M	﹤0.01%	914
2020 Q4	–	Sell	-12,500	Closed	-$3.22M	–	1443
2020 Q3	$3.22M	Buy	+12,500	New	+$2.77M	0.01%	572

Canada Pension Plan Investment Board's RAPT Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 8,800 shares — an estimated $298K sold.

Canada Pension Plan Investment Board first reported a position in RAPT in Q3 2020 and held it in 3 quarters. The position peaked at $3.22M in Q3 2020. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Canada Pension Plan Investment Board reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Canada Pension Plan Investment Board sold 8,800 RAPT Therapeutics shares in Q1 2026, an estimated $298K.
Canada Pension Plan Investment Board first reported a position in RAPT Therapeutics in Q3 2020 and held it in 3 quarters.
Canada Pension Plan Investment Board's RAPT Therapeutics position peaked at $3.22M in Q3 2020.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.